Re a top 20, I have only compared the top 20 from successive annual reports.
Edwin Lefevre is the author of "Reminiscences of a Stock Operator"
and Henri is my first name.
I think they are very focussed on the science.
Management is everything and I have met Liz a few times and she has brought on board an incredibly well credentialled team.
Dianne Angus is the recent appointment as Non Exec Chair and she would be attracting several funds following her from Neuren Pharmaceuticals looking to take a groundfloor investment in Argenica. Argenica's markets are multiples of the size of Neurons.
Good luck to everbody.
Re a top 20, I have only compared the top 20 from successive...
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.5¢ |
Change
0.010(1.71%) |
Mkt cap ! $73.07M | |||
| Open | High | Low | Value | Volume |
| 60.0¢ | 61.5¢ | 59.0¢ | $78.11K | 130.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4999 | 59.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 60.0¢ | 19915 | 1 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
60.5¢ |
Change
0.010 ( 4.31 %) |
||||
| Open | High | Low | Volume | ||
| 59.0¢ | 61.0¢ | 59.0¢ | 61277 | ||
| Last updated 15.23pm 06/05/2024 ? | |||||
| AGN (ASX) Chart |